Mit45

As of March 2024, the company has been the subject of a civil class action lawsuit alleging misleading sales practices and failure to disclose that kratom's active ingredients act on the same receptors as opioids, carrying risks of addiction and withdrawal.

The Better Business Bureau (BBB) has noted that the company has not substantiated certain health claims—such as increased energy or mental clarity—as of late 2024. Company Culture Working at MIT45: Employee Reviews | Indeed.com As of March 2024, the company has been

The brand claims to use independent labs to verify alkaloid levels and screen for heavy metals or pathogens. As of March 2024

Their signature "Gold" shot is a concentrated tincture with a 45% mitragynine concentration. As of March 2024, the company has been